Dr. Kleinman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2412 N John B Dennis Hwy
Kingsport, TN 37660Phone+1 423-578-4364Fax+1 423-578-4372
Education & Training
- University of Kentucky College of MedicineFellowship, Surgical Retina and Vitreous, 2011 - 2013
- University of Kentucky College of MedicineResidency, Ophthalmology, 2008 - 2011
- University of Kentucky Albert B. Chandler HospitalPost-Doctoral Fellowship, 2006 - 2008
- NYU Grossman School of MedicineInternship, Transitional Year, 2005 - 2006
- New York University School of MedicineClass of 2005
- Emory UniversityB.S., Biology/Chemistry, 1994 - 1998
Certifications & Licensure
- TN State Medical License 2018 - 2026
- VA State Medical License 2018 - 2026
- KY State Medical License 2011 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- BrightFocus Award for Macular Degeneration Research 2018
- Ophthalmologist of the Year Award Kentucky Academy of Eye Physicians, 2017
- Young Physician-Scientist Award ASCI, 2016
- Join now to see all
Clinical Trials
- A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 154 citationsHypoxia-Induced Mediators of Stem/Progenitor Cell Trafficking Are Increased in Children With HemangiomaMark E. Kleinman, Matthew R. Greives, Samara S. Churgin, Keith M. Blechman, Eric I. Chang
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007-12-01 - 533 citationsCorneal avascularity is due to soluble VEGF receptor-1Balamurali K. Ambati, Miho Nozaki, Nirbhai Singh, Atsunobu Takeda, P. Jani
Nature. 2006-10-26 - 697 citationsSequence- and target-independent angiogenesis suppression by siRNA via TLR3Mark E. Kleinman, Kiyoshi Yamada, Atsunobu Takeda, Vasu Chandrasekaran, Miho Nozaki
Nature. 2008-04-03
Journal Articles
- Vision Loss in Juvenile Neuronal Ceroid LipofuscinosisOuseph M, Kleinman ME, Wang Q, Ann N Y Acad Sci, 1/1/2016
- Therapeutic Approaches to Histone Reprogramming in Retinal DegenerationBerner AK, Kleinman ME, Adv Exp Med Biol, 1/1/2016
- Complement Activation and Inhibition in Retinal DiseasesKleinman ME, Ambati J, Dev Ophthalmol, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The Future of Ophthalmic Imaging.Kleinman ME, Cincinnati Ophthalmology Society, Spring, 1/1/2017
- Safety and efficiency of CRISPR-Cas9 gene editing in the retinal pigment epithelium.Kleinman ME, Dubey S, Jung K, Roney J, Lou D, Brown J, Mohan K, Annual ARVO Meeting, Baltimore, MD, 1/1/2017
- Epigenetic Regulation of Type I IFN Response in Age-Related Macular Degeneration.Sung K, Lou D, Mohan K, Dubey S, Prajapati SC, Roney J, Abney JL, Liu J, Kleinman ME, Keystone Interferon Meeting, Banff, Alberta, Canada, 1/1/2017
- Join now to see all
Lectures
- Current Therapies for AMD.Baltimore, MD, 2013; Denver, CO, 2014 - 1/1/2014
- Update on AMD Research.1/1/2013
- Employing Ocular Electrophysiology in Your Practice.1/1/2013
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: